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Abstract 
 
Introduction: Human ear reconstruction is recognized as the emblematic enterprise in tissue engineering. 
Up to now, it has failed to reach human applications requiring appropriate tissue complexity along with 
an accessible vascular tree. We hereby propose a new method to process human auricles in order to 
provide a poorly immunogenic, complex and vascularized ear graft scaffold. 
Methods: 12 human ears with their vascular pedicles were procured. Perfusion-decellularization was 
applied using a SDS/polar solvent protocol.  Cell and antigen removal was examined by histology and 
DNA was quantified. Preservation of the extracellular matrix (ECM) was assessed by conventional and 
3D-histology, proteins and cytokines quantifications. Biocompatibility was assessed by implantation in 
rats for up to 60 days. Adipose-derived stem cells seeding was conducted on scaffold samples and with 
human aortic endothelial cells whole graft seeding in a perfusion-bioreactor. 
Results: Histology confirmed cell and antigen clearance. DNA reduction was 97.3%. ECM structure and 
composition were preserved. Implanted scaffolds were tolerated in vivo, with acceptable inflammation, 
remodeling, and anti-donor antibody formation. Seeding experiments demonstrated cell engraftment and 
viability. 
Conclusions: Vascularized and complex auricular scaffolds can be obtained from human source to 
provide a platform for further functional auricular tissue engineered constructs, hence providing an ideal 
road to the vascularized composite tissue engineering approach.  
 
Keywords. Human; Ear graft; Perfusion-decellularization; Extracellular matrix; Vascularized Composite 
tissue Engineering. 
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1. Introduction  
 
Reconstruction of sizable auricular defects represents an enduring challenge in the field of plastic surgery, 
with variable clinical results despite extensive approaches and experimentation. Conventional autologous 
techniques[1-4] produce donor site morbidity and are limited by surgeon experience and expertise. The 
use of prosthetic cartilage implants has been reported, however the risk of extrusion has limited clinical 
applicability [5]. Vascularized Composite tissue Allotransplantation (VCA), whereby cadaver auricles are 
harvested and implanted into a recipient, are not available for single subunit reconstruction, since 
immunosuppressive (IS) treatment is not acceptable for such a small, non-life saving transplant [6]. In 
theory, tissue engineered (TE) autologous auricular implants may be able to overcome the limitations of 
current techniques [7-9], unfortunately the move from bench to bedside has yet to be achieved. Barriers to 
the success of TE auricles include the challenge of reproducing the biological complexity of human tissue 
along with the challenge of creating and accessing a vascular tree necessary for sustainment of seeded 
cells and implantation into a recipient. The perfusion-decellularization technique, as previously described 
in organs [10-14] and composite tissues [15-17], may represent the ‘holy grail’ of immunosuppression-
free auricular transplantation. The basics of this technique involve circulating a mild detergent through a 
harvested organ/tissue via the native vascular system with the goal of removing cellular components, thus 
creating an extracellular matrix (ECM) scaffold retaining original tissue architecture and properties. The 
ECM scaffold could then be repopulated with autologous cells that would lead to a biological identity 
reassignment and immune tolerance once implanted. This technology appears ideally suited for the 
creation of a clinically useful bioengineered auricle. We previously reported the application of the 
perfusion-decellularization technique in porcine ear and human face models, with successful graft 
decellularization, preservation and accessibility of the vascular tree, suitable for repopulation with new 
cells and allocompatibility [18,19]. We hypothesized that this technology can be applied to human ear 
grafts. We hereby propose here a method to process cadaveric human auricles, in order to provide a 
poorly immunogenic, complex and vascularized ear graft scaffold. Indeed, the relatively robust nature of 
composite tissues to post-mortem degradation could allow successful transplant processing, defining the 
new auricular synthesis approach of Vascularized Composite tissue Engineering (VCE). 
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2. Materials and Methods  
2.1 Specimens. Twelve ear grafts were harvested from eight human cadaveric donors at the Université 
catholique de Louvain human anatomy department (Brussels, Belgium). Prior to passing, all donors had 
consented to research and teaching on their body. Donors were aged 68 to 104 years at the time of death. 
Bodies were preserved at 4°C for 1 to 4 days prior to graft procurement. All animal experiments were 
approved by the Université catholique de Louvain Animal Ethics Committee and following the EU 
Directive 2010/63/EU for animal experiments. 
2.2 Ear graft procurement and perfusion-decellularization. According to previously described 
surgical protocol [20,21], ears were harvested with their corresponding vascular and nervous pedicles. 
Briefly, a peri-auricular incision was made within 1 cm around auricular implantation and continued to 
the temporal and cervical regions. In the cervical region, the common carotid artery, external carotid 
artery, posterior auricular artery (PAA), proximal superficial temporal artery (STA), external jugular vein 
and great auricular nerve were isolated. All other arterial branches and collaterals were ligated. After 
temporal incision, distal STA and vein were identified and dissected distally to frontal and parietal 
branches. Pre-auricular STA dissection and exposure was completed through the parotid gland. 
Superficial temporalis fascia was incised circumferentially, then elevated by blunt subfascial undermining 
down to the zygomatic arch of the temporal bone aiming to reach the external acoustic meatus and 
posteriorly, to the external aspect of the mastoid process. During this retrograde dissection, the PAA was 
protected. Finally, the ear completely elevated, along with its pedicle. Contralateral ear was either 
harvested identically or simply explanted as control. A luer was inserted in the arterial pedicle for 
heparinized saline (15 UI/ml) irrigation of the graft. This solution was infused until clear return was 
identified, in veins left free. Complementary vascular control was performed with either suture ligation or 
microclips. Remaining parotid tissue was excised then each ear was weighted. The arterial catheter was 
then connected to a Masterflex L/S peristaltic pump with L/S easy load pump head and L/S 16G tubing 
(Cole-Palmer Instrument Co, Vernon Hills, IL, USA) after final immersion in a 1L glass jar filled with 
the same solution as perfused. Perfusion-decellularization sequence, in an open circuit fashion, followed 
eight steps: (1) 1000 ml of heparinized saline (15UI/ml), containing 10 M adenosine (Sigma-Aldrich, St. 
Louis, MO), 4°C; 1% sodium dodecyl sulfate (SDS, VWR, Radnor, PA) in deionized water (DIW) was 
perfused for 88 hours (36500 ml), room temperature (RT). This treatments leads to epidermolysis and 
bullae formation, tissue bleaching and edema formation, while shape is preserved; (3) DIW was then 
perfused for 3 hours (1200 ml), RT; (4) Triton-X 100 1% (VWR) in DIW for 25 hours (10000 ml), RT; 
(5) Phosphate buffered saline (PBS) for 38 hours (16000ml), RT; (6) Polar solvent step (100% 2-propanol 
, VWR), as previously described [22,23],  whereby the flap was perfused for 4 hours (1000 ml), until 
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critical increase of vascular resistances, then transferred to a stirring bath of polar solvent overnight at RT, 
changed once, then rinsed in DIW bath for 2 hours, and finally perfused with PBS for 30 hours (16000 
ml). This treatment removes oil from adipose tissue layer; (7) Type I Bovine DNAse (Roche I, Sigma), 50 
UI/ml in PBS with 203.3 M magnesium chloride (Sigma), for 6 hours (900 ml), 37°C; (8) final wash of 
the auricle with PBS for 12 hours (4500 ml), RT. For all steps flow rate was set between 6 and 8 ml/min, 
in order to observe a mean arterial pressure (MAP) under 80 mmHg, with exception of DNAse 2 ml/min 
perfusion. Decellularized human ears (HE-ECM) were stored at 4°C in PBS. Before tissue analysis, each 
HE-ECM was weighted, examined for epidermis and hair remnants, bleaching and morphology.   
2.3 Arterial pressure monitoring. During all steps of perfusion-decellularization, with exception of 
polar solvent perfusion, MAP was recorded with a central line connected to a Datex-Ohmeda S/5 
anesthesia monitor and M-Prestin module (GE Healthcare Life Sciences, Chicago, IL, USA) for a 
selected pump inflow. A MAP profile was established for a constant flow of 8 ml/min. 
2.4 Fluoroscopic vascular assessment. Contrast agent (Visipaque, GE Healthcare) mixed with normal 
saline (1:2) was injected in the arterial pedicle by a constant manual syringe pressure, for a HE-ECM 
scaffold compared to a native ear graft. Image acquisition was performed with a Powermobil C-Arm 
(Siemens, Munich, Germany). Images were exported in DICOM format and visualized with Osirix© 
software (Pixmeo, Bernex, Switzerland). 
2.5. Histology, immunohistochemistry (IHC), immunofluorescence (IF) 
Paraffin-embedding. Tissues were fixed in 4% formalin for 24 hours, transferred in successive toluene 
and alcohol baths prior to dehydration, then embedded in paraffin and sectioned into 5μm slices.  
Histological staining. Sections were deparaffinized and rehydrated. We used hematoxylin and eosin 
(H&E), Masson’s trichrome (MT), alcian blue and safranin O stains according to standard protocols. 
Miller’s elastin/alcian blue/sirius red stains were also performed as described [24] in order to stain elastic 
fibers (purple), sulfated glycosaminoglycans (GAGs) (blue) and collagen (red). 
IHC. After deparaffinization, slides were subjected to antigen retrieval by heating at 98°C for 60 min in 
10 mM citrate buffer, at pH 5.7. Endogenous peroxidases were inhibited using 1% H2O2 and non-specific 
antigenic sites were neutralized with 1:50 goat serum. Samples were incubated at 4°C overnight, using the 
primary antibodies: anti-MHC type I + HLA A + HLA B (ab134189, 1:200, Abcam, Cambridge, UK) and 
anti-CD31 (ab28364, 1:50, Abcam). Next, the sections were successively incubated with 1:50 biotinylated 
secondary antibody, stained with streptavidin-HRP (Sigma) and 3,3’-diaminobenzidine (DAB) peroxidase 
substrate (Vector laboratories, Burlingame, Ca, USA), followed by counterstaining in Mayer’s 
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hematoxylin for 1minute, dehydration in alcohol and toluene baths and finally mounting with Entellan 
mounting medium. PBS containing 1% bovine serum albumin (BSA) was used to rinse sections after each 
step. 
IF. Deparaffinized, formalin-fixed sections were quenched with NaBH4 (1:100), then subjected to 
antigen retrieval by heating at 98°C for 60 min in 10 mM citrate buffer, pH 5.7. Samples were incubated 
at 4°C overnight with the following primary antibodies: anti-type I collagen (ab34710, 1:250, Abcam), 
anti-type II collagen (ab34712, 1:200, Abcam) and anti-type IV collagen (ab6586, 1:500, Abcam). 
Neutralization of nonspecific sites was done with PBS containing 5%BSA. For fluorescence staining, 
secondary antibody labeled with Alexa Fluor 488 (goat anti-Rabbit or anti-mouse IgG, 1:300, 
ThermoFisher Scientific, Whaltam, MA), was used and the nuclei were stained with 4’-6-diamindino-2-
phenyl-indole (DAPI, 1:1000) and mounted with DAKO fluorescent mounting medium (Agilent, Santa 
Clara, CA, USA).  
Lipid droplet evaluation on frozen sections. Tissue-Tek O.C.T. Compound (Sakura Finetek, Alphen 
aan den Rijn, The Netherlands) embedded biopsies were cut on a Microm HM 560 cryostat 
(ThermoFisher). Sections were cut to 5μm thickness and processed for the staining.  For type IV Sudan 
(Sigma) staining, sections were fixed for 10 min in 4% formaldehyde directly after thawing, washed, 
incubated for 30 min in a Sudan IV saturated solution, washed and mounted. 
Histology and IHC sections were digitalized at 40x magnification with a SCN400 slide scanner (Leica, 
Wetzlar, Germany) and visualized using Digital Image Hub (Leica Biosystems, Dublin, Ireland). Images 
of IF sections were acquired on a Zeiss AxioImager.z1fluorescence microscope (Zeiss). 
2.6 3D-histology serial reconstruction and analysis: Full-thickness biopsies were taken from a native 
ear and a HE-ECM graft. For each sample, 50 serial sections of 5 µm thickness were prepared with 
Miller’s elastin/alcian blue/sirius red stains. Slides were scanned using the SCN400 slide scanner (Leica) 
with a 40x objective. Damaged sections were discarded after visual examination (2-3 sections per sample) 
and 3D-reconstruction was performed using the HeteroGenius MIM 3D Pathology add-on (HeteroGenius 
Ltd, Leeds, UK) with 4 levels of non-rigid alignment (1.25X, 2.5X, 5X and 10X) and a final B-Spline 
size of 12x12mm, subsequent to automatic rigid alignment of sections performed at 1.25X. Whole sample 
3-D visualization of original data (~1000x1000x50 voxels) was produced, with a total volume of 7.61 
mm
3
 and 8.21 mm
3
 in the native ear and HE-ECM graft samples respectively. Subvolume analysis data, 
defined by volumes of interest in the cartilage, skin and connective tissue, from both native and 
decellularized samples, was annotated manually on a single slide, using a box of approximately 1 x 1 x 
0.25mm. Animated Graphics Interchange Format (GIF) images of the whole stack were produced by 
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exporting the aligned stack volumes from HeteroGenius MIM and using ImageJ software [25] for volume 
rendered examples. 
Quantitative analysis of porosity was performed on tissue samples using the HeteroGenius MIM Colour 
Analysis add-on. A 3-class (collagen, elastin and background) probabilistic model was built by manually 
labelling examples of each class. Pixel counting for each class was performed for a single annotated sub-
region per image, by classifying a pixel as belonging to the class if the probability of class membership 
was 0.75 or larger (“QuantifyByColour” analysis method). Annotation of the tissue region was performed 
automatically at 0.625X resolution, which uses a greyscale threshold (value=200), plus morphology, hole 
filling and boundary tracing to annotate tissue pieces with a Bezier curve. Porosity was obtained by the 
ratio between non-stained and stained volumes between a native and a decellularized serial-sectioned 
samples. Additionally, annotations excluding the cartilage were produced manually for a subset of 2 
images per sample. 
2.7 Scanning Electron Microscopy (SEM). Native and decellularized biopsies were fixed with 2.5% 
glutaraldehyde overnight at 4°C. Samples were then washed with PBS and gradually dehydrated by 
successive immersion in increasing concentrations of ethanol for 15 min each. Before SEM imaging, 
tissues were critical-point dried and coated with an 8-nm gold layer. SEM measurements were performed 
at 15 keV. Samples were observed with a field-emission scanning electron microscope (JSM-7600F, Jeol, 
Akishima, Tokyo, Japan) according to standard protocols. 
2.8 DNA quantification. DNA of skin (n=6), fat (n=4) and cartilage (n=3) samples from native ear (n=3) 
and HE-ECM (n=3) was extracted, with DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany), 
processing up to 25 mg biopsies. Briefly, tissues were incubated overnight at 56°C with proteinase K (40 
mAU/mg protein) solution. After adding buffer and ethanol, the mixture was transferred to a spin column 
filled with buffers and repeated elution was performed. Extracted DNA content was assessed by Quant-
it Picrogreen dsDNA assay kit (ThermoFischer Scientific), according to manufacturer’s protocol. Final 
value was expressed in ng DNA per mg tissue wet weight. 
2.9 ECM protein quantification. Biopsies of skin (n=6), fat (n=4) and cartilage (n=3) samples from 
native (n=3) and decellularized (n=3) different ear grafts were used. Collagen content was evaluated using 
a Chondrex hydroxyproline assay kit (Chondrex, Inc., Redmond, WA) according to manufacturer’s 
protocol. Briefly, samples were hydrolyzed in 10M hydrochloric acid for 24 hours at 100°C, and mixed 
with hydroxyproline standards. Chloramine-T was added to solution from samples and standards, then 
incubated 20 min at room temperature. DMAB was added to standards and samples solutions, then 
incubated at 60°C. Absorbance was read at 570 nm. GAGs content was evaluated using the Blyscan 
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Sulfated-GAG assay kit (Biocolor LTD, Carrickfergus, Northern Ireland) according to manufacturer’s 
recommendations; samples extraction was proceeded with papain overnight at 65°C. After centrifugation, 
supernatant was collected and color reactant was added to precipitate S-GAGs, followed by repeated 
centrifugation until dissociation was completed. Standard was bovine tracheal chondroitin 4- sulfate. 
Absorbance was read at 630 nm.  Elastin content was measured with the Fast Elastin Assay kit (Biocolor) 
according to manufacturer’s recommendations. 0.25M oxalic acid was added to samples, and digested for 
one hour at 100°C before supernatant collection. This extraction was repeated two times for skin and fat 
and three times for cartilage and muscle. Final extraction volume was mixed with equal reactant volume 
for elastin precipitation until complete elastin digestion and centrifuged. Colored reactant was added in 
the remaining solution, stirred and centrifuged prior to supernatant elimination. Standard was a high 
molecular weight fraction of α-elastin prepared from bovine neck ligament elastin in oxalic acid 
Absorbance was read at 510 nm. All results were expressed as µg/mg wet weight. 
2.10 Mechanical properties. We used an Instron-5666 universal testing machine (Instron Corporation) 
for all experiments. Ball burst tests were performed to determine the stiffness of the cartilage. A 4-mm 
diameter steel ball with 1mm/min loading rate, and a 100N load cell, was applied to decellularized (n=5) 
and native (n=5) disc samples each from a different donor, clamped in 5-mm diameter O-rings. Endpoint 
was the maximum force. Stiffness was expressed as the ratio between the maximum force and the 
corresponding crosshead displacement. Values were divided by sample thickness and expressed as N/mm. 
Tensile tests were performed to determine the stress-strain response of native (n=4) and decellularized 
(n=6) skin samples, originated from different donors. Rectangular cross section samples were submitted 
to a tensile load with a 1 mm/min crosshead speed and a 20 mm initial grip distance. 
2.11 Cytokines quantification 
Protein extraction. Skin, cartilage and fat tissue biopsies were collected from native (n=4) and 
decellularized ear grafts (n=3). Samples were kept at 4°C until processing. Biopsies were weighed on an 
analytical scale and cut into small pieces with a surgical knife. The pieces were transferred into M tubes 
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) containing RIPA buffer (50mM Tris-HCl, pH 
8.0, with 150mM sodium chloride, 1.0% Igepal CA-630 (NP40), 0.5% sodium deoxy cholate and 0.1% 
sodium dodecyl sulfate) laced with protease inhibitor cocktail (P8340, 1:100, SIGMA). M tubes were 
promptly inverted and put on a gentle MACS Dissociator (Miltenyi Biotec GmbH), then homogenized 
using the program specific for protein extraction. After termination of the program, homogenates were 
incubated on ice and underwent sonication. After a short spin down, the supernatant was transferred to 
smaller tubes for centrifugation at 13’000 rpm for 1 hour at 4°C. Again, the supernatant was transferred to 
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a new tube for further analysis. For protein quantification, a classical Bicinchoninic acid (BCA) assay was 
performed. A bovine serum albumin standard (2.0mg/ml in 0.9% aqueous NaCl containing sodium azide, 
23209, Thermo Fisher Scientific) was prepared and transferred to a flat transparent 96-well plate (Thermo 
Fisher Scientific). 5μl of sample were added to the wells and the assay was performed according to the 
DC Protein Assay kit instructions (Bio-Rad, Hercules, CA, USA). The OD was measured at 750nm on a 
plate reader (Infinite M1000 PRO) and interpolated by Prism 7 (GraphPad Software, La Jolla, CA, USA). 
Cytokine measurement. Protein levels of 42 different cytokines were measured by Bio-Plex multiplex 
immunoassays. The Bio-Plex Pro Human Chemokine 40-Plex Panel (Bio-Rad) and the Bio-Plex Pro 
TGF-β 3-Plex kit (Bio-Rad) were used to analyze the supernatants of the protein extraction (above) and 
run on a FLEXMAP 3D system (Luminex, Austin, CA, USA). The procedure was performed based on 
the original manufacturer instruction manual. Growth factor content was normalized to the mass of 
starting tissue and expressed as pg of analyte per mg of tissue. After log2 transformation, concentrations 
above or below the limit of detection were eliminated from the analysis. 
2.12 In vivo biocompatibility study. 16 adult Wistar rats (all females, mean weight = 208±15 g) were 
implanted subcutaneously with 2 biopsies, helix and lobe of approximately 7x7x3 mm, from either native 
ear (n=8) or HE-ECM (n=8), previously sterilized by 0.1% peracetic acid (PCA). Samples came from 
three different donors in each group (control versus decellularized). Within each group, we used the same 
three different donors for each period of sacrifice (day 15, day 30, day 60 – with exception of this last 
group involving only two different donors. General anesthesia was performed using intra-peritoneal 
injection of 50 mg/ml Ketamine with 20mg/ml Xylazin in saline. After disinfection, a median incision 
was performed on the abdomen and two subcutaneous pockets were created. For serum collection, 1ml 
blood puncture was performed at time of implantation and sacrifice; collected blood was then centrifuged 
15 min at 3000 rpm, and serum preserved at -80°C. Euthanasia was performed at postoperative day 
(POD)15 (n=6), POD30 (n=6) and POD60 (n=4); then implants were retrieved, paraffin-embedded, 
sectioned and stained with H&E, MT, anti-CD68 (ab31360, Abcam) and anti-CD3 (ab16669) with IHC. 
For inflammatory and lymphocytic quantification, CD68- and CD3- stained sections were digitalized with 
the slide scanner and analyzed using the image analysis tool (Author version 6.6.3, Visiopharm, 
Hørsholm, Denmark). The implant in each section was delineated manually and care was taken to exclude 
tissue folds and artefacts from the analysis. CD68- and CD3-positive pixels were then detected within the 
previously delineated tissue at high resolution (20x) using a classification based on image feature 
highlighting the DAB staining (HDAB-DAB matrix of the software). Threshold was adjusted on 
representative stained vs non-stained tissue areas. The results were expressed as CD68- and CD3- stained 
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area percentages and calculated as -stained area/total tissue area ×100. The parameters were kept constant 
for all slides. 
Detection of anti-donor alloantibody (IgG) by flow cytometry. Human peripheral blood 
mononucleated cells (PBMC), freshly taken from a healthy donor, were incubated with recipient serum 
for 30 min at room temperature. Before incubation, the serum was decomplemented for 30 min at 56°C. 
After washing with fluorescence-activated cell sorting buffer (Hanks balanced salt solution – HBSS – 
containing 0.5% fetal bovine serum and 0.1% sodium azide), saturating amounts of Alexa Fluor 488 goat 
anti-rat IgG polyclonal antibody (Thermo Fisher Scientific, Merelbeke, Belgium) was added and 
incubated for 30 min at room temperature, then washed twice. Each analysis included the appropriate 
Alexa Fluor 488-conjugated antibody with only PBMCs, for nonspecific reaction. Cells were acquired 
and analyzed with BD FACSCalibur (BD Bioscience Benelux NV, Erembodegem, Belgium) driven by 
CellQuest Pro software (BD Bioscience). A positive reaction was defined as a shift of more than 10-
channels in mean fluorescence intensity when testing donor lymphocytes with post-transplantation (Day 
15, 30 and 60) serum and comparing with pre-transplant serum (Day 0). 
2.13 Scaffold seeding with rodent adipose-derived stem cells 
Rat Adipose-derived Stem Cells (rASCs). rASCs were isolated as previously reported [26]: briefly, we 
retrieved fresh inguinal fat from one adult rat, right after euthanasia for other experiments. Fat was 
digested with type II collagenase (LS004176, Worthington, Lakewood, NJ, USA), reconstituted in HBSS, 
and incubated for 1h at 37°C with continuous agitation for 60 min. After digestion, the collagenase was 
inactivated in Dulbecco’s Modified Eagle’s Medium (DMEM, Westburg, Leusden, The Netherlands) 
supplemented with 10% FBS, 2 mM L-glutamine, penicillin 100 U/mL, and streptomycin 100 µg/mL. 
Collected tissue was centrifuged for 10 min at 1500 rpm, at room temperature. The supernatant was 
aspirated and cells pellet was suspended with DMEM with 10% FBS, 2 mM L-glutamine, penicillin 100 
U/mL, and streptomycin 100 µg/mL. After filtration through a 500-µm mesh screen, the collected tissue 
was centrifuged for 10 min at 1500 rpm, at room temperature and the pellet was suspended in 
proliferation medium and identified as the stromal vascular fraction (SVF). After 24-48 h of incubation at 
37°C in 5% CO2, the cultures were washed with PBS and maintained in proliferation medium, containing 
DMEM with 4.5g/L glucose w/o L-Glutamine supplemented with 10% of FBS, 1% of P/S and 1% of 
Glutamine.and trypsinized when reaching 80% confluence, up to 4 passages. 
Scaffold sample seeding: Decellularized HE-ECM samples (n=9), from external carotid artery pedicle 
(D-Artery, n=2), dorsal skin (D-Skin, n=2) and helix full-thickness (D-FT, n=4) biopsies, were sterilized: 
briefly, 0.1% PCA (Sigma) was prepared with DIW, and sterilized with a filtration unit. Samples were 
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then washed overnight in PCA, using an orbital stirrer. Samples were then rinsed with DIW and repeated 
PBS washes on orbital-shaker, and finally preserved in sterile PBS/AA. Scaffolds were positioned in a 
24-well plate, then impregnated with supplemented DMEM (10% of FBS, 1% of P/S and 1% of 
Glutamine). rASCs were seeded at a density of 3.6x10
4
 cells/ cm
2 
on each scaffold. All seeded HE-ECM 
were then placed in a CO2 incubator, and cultivated under standard conditions. Medium was changed 
every 48h for 14 days. At retrieval, biopsies were first treated as whole-mounts with vital staining then 
Vybrant MTT (4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) Cell Proliferation Assay Kit 
(Life Technologies) was used, mixing 12mM MTT with PBS. Next, specimens were incubated with 
scaffold for 4 hours at 37°C observed under a binocular microscope, and with Live/Dead 
Viability/Cytotoxicity Kit (Life Technologies, L3224), incubating 2mM ethidium homodimer and 4mM 
calcein-AM with samples for 40 min at room temperature. The rest of the constructs were paraffin-
embedded, sectioned and stained with H&E. 
2.14 Bioreactor whole-graft human aortic endothelial cells (HAEC) seeding 
Scaffold preparation. A whole HE-ECM graft was sterilized using 0.1% PCA protocol of alternating 
bath-stirring and perfusion, under sterile conditions, as previously described  [18]. The HE-ECM was then 
mounted in a sterile perfusion-bioreactor, in closed circuit with the arterial pedicle connected to the tubing 
and the veins left free in the jar. The perfusion chamber was filled with 900 ml DMEM and graft 
conditioned for 2 hours with perfusion set at 5 ml/min, in a CO2 incubator, set at 37°C and 5%CO2. 
HAEC isolation and culture . Purchased HAEC ((304-05A, Sigma-Aldrich) were cultivated on 0.2% 
gelatin (Sigma G1393), with Endothelial Cell Growth Medium MV2 (Bio-Connect, Toronto, Canada), 
changed twice a week, and cells amplified 6 times once a week (standard passage) until passage four. 
Bioreactor whole-scaffold vascular seeding and culture. After scaffold immersion in 500ml 
Endothelial Cell Growth Medium MV2, 30x10
6
 HAEC suspended in 7 ml medium were slowly injected 
through the arterial line. After a four-hours static period, to allow endothelial cell attachment, the 
perfusion flow was restarted at 2ml/min overnight, then increased to 6 ml/min. After 48 hours, the culture 
was stopped; biopsies were processed for Live/Dead, MTT and CD31 IHC stainings. 
2.15 Statistical analysis. Graphic presentation and statistical analysis was performed on Prism 7 
(GraphPad Software). For GAGs, elastin and collagen content, unpaired student t-tests were performed 
between native and decellularized ear samples. For cytokines, two-sample t-tests with Benjamini, Krieger 
and Yekutieli correction were performed to quantitatively compare their abundance in native and 
decellularized tissues. One-way ANOVA with post-hoc Tukey’s multiple comparison correction was used 
  
12 
 
to compare the relative preservation of the different cytokine groups within the analyzed tissues. Data are 
presented as mean ± SEM for all analysis with exception of cytokines quantification expressed as mean ± 
SD. P <0.05 was considered statistically significant. 
 
3. Results  
3.1 Perfusion-decellularization. Blistering was observed within the first 12h of SDS perfusion, first 
affecting the posterior surface followed by the anterior surface of the graft. The blisters evolved into large 
bullae which led to complete epidermis removal (FIG 1A-B). After completion of the Triton-X step, a 
yellowish aspect of the adipose tissue remained, demonstrating scattered oil cysts. Adipose tissue was 
satisfyingly treated after the supplementary 2-propanol step, as confirmed by macroscopic observation 
and type IV Sudan staining (FIG 1C-D). After the final PBS step, the cartilage layer retained the original 
auricular morphology. Arterial vascular patency was confirmed by fluoroscopy (n=2), with opacification 
of ECA, PAA and STA axis and their distal parenchymal branches, without signs of intra-graft contrast 
extravasation (FIG 1E, supplementary material 1 video). Venous outlet couldn’t be assessed with this 
analysis: the liquid drops observation only reflected the quality of the venous vascular control at graft 
section, more difficult in decellularized ears, with however no impact on the quality of the 
decellularization and the patency of the vascular tree; the venous obstruction, correlated to parenchyma 
edema formation, was very limited. Regarding MAP evolution during protocol, SDS perfusion was 
associated with an important increase of arterial vascular resistances, macroscopically associated with 
edema of the fat layer; MAP decreased as steps were followed, and finally came back to initial MAP 
value after decellularization completion (FIG 1F).  
3.2 Cell clearance. H&E and DAPI confirmed cellular clearance in skin and adnexa, with a few remnant 
chondrocyte nuclei visible in the deep cartilage, associated with negativity of type I MHC markers in 
treated grafts (FIG 2A-C). The complete nuclei clearance could be observed already before DNAse 
perfusion (see supplementary material 2). CD31 markers of endothelial cells were also completely 
removed (FIG 2D). DNA quantifications in D-Skin, D-Fat and D-Cartilage were found to be respectively 
0.99±0.75, 0.84±0.56 and 4.82±3.95 ng/mg wet weight compared to 88.7±9.6, 28.2±15.7 and 121.7±31.1 
ng/mg wet weight in native samples; this represented an overall 97.3% DNA reduction in HE-ECM 
(p<0.001) (FIG 2E).  
3.3 ECM preservation.  
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3.3.1 Histology. MT, type I and type II collagen stains confirmed the high-quality preservation and 
structural organization of major collagen proteins (FIG 3A-C). Type IV collagen, which is fundamental 
for basal membranes and critical for further epidermal reconstruction strategies, was well-observed in the 
vessels, glands and especially in the dermis, at the level of the dermo-epidermal junction (DEJ) (FIG 3D). 
Alcian blue and safranin O stains demonstrated GAG preservation in the cartilage layer, with some 
reduction in peripheral areas more exposed to the decellularizing flow agents through the perichondrium 
(FIG 3E-F). 
SEM examination reveals the preservation of the HE-ECM ultrastructure with dermal papillae, cartilage 
with emptied chondrocyte lacunae, and fat with fibrillary organization and absence of oil cysts. No 
detergent crystal could be detected in examined samples, revealing the efficiency of PBS perfusion to 
remove them (FIG 3G-J). 
3.3.2 ECM protein quantification. The qualitative ECM assessment was correlated to the preservation 
of its major protein content (FIG 3K-M). Collagen was highly preserved in D-Skin, D-Fat and D-
Cartilage (87.2±14.3, 126.5±52.5 and 36.7±12.3 g per mg wet weight respectively) compared to controls 
(20.3±8.2, 41.2±23.2 and 21±8 g per mg wet weight respectively), representing a mean relative increase 
in collagen content of 300 % compared to native tissues. The global content increase is explained by 
collagen preservation following perfusion-decellularization, as well as by the reduction of cell content and 
other ECM proteins, leading to an important relative mass increase in all ear scaffold tissues. Mean elastin 
content in D-Skin, D-Fat and D-Cartilage was 4.96±1.5, 3.96±0.99 and 13.64±1.8 g per mg wet weight 
respectively, compared to 16.68±4.41, 14.53±6.44 and 14.98±6.92 g per mg wet weight respectively in 
controls. Reduction of elastin was significant in skin (p0.05), with 41.3% relative preservation of elastin 
content while in cartilage 82% of native elastin content was preserved with non-significant difference. For 
GAGs, D-Skin, D-Fat and D-Cartilage was 0.2±0.1, 0.33±0.01 and 2.82±1.2 g per mg wet weight 
respectively, compared to 0.53±0.01, 0.47±0.11 and 7.23±0.65 g per mg wet weight respectively in 
controls. D-Skin preserved 42.6% of native GAG content while GAG value represented 40% of native 
content preservation for D-Cartilage (p0.05). It is vitally important that both elastin and collagen content 
are preserved in cartilage, as they are primarily responsible for the mechanical properties of cartilage: 
indeed, preservation of the morphological support is one of the most important feature for auricular graft 
functionality. 
3.3.3 The tridimensional structural preservation of specific elements of the composite tissue is 
appreciated (elastin, collagen, GAGs), by the 3D-ECM histological reconstructions. From these samples, 
we extracted a volume of subunits for 3D reconstructions (FIG 4A-B), enabling a better targeted 
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structural assessment. The 3D cartilage subunit evaluation confirmed the 2D histology observation and 
quantification, with a better characterization of the cartilage lacunae density and staining preservation. 
For the skin, the 3D volume confirmed the presence of intact dermal papillae and adnexal removal. The 
connective tissue, including deep dermis, adipose tissue, vessels and glands appeared at a lesser density. 
On the 3D volumes quantification, the porosity of whole-biopsy volume was increased in the 
decellularized sample, with a mean non-stained ratio to stained areas of 32.2±2.2%, compared to 
20.8±2.6% in the native sample (FIG 4C). When excluding the cartilage, the porosity in HE-ECM was 
even higher, with 46%, signifying the loss of structural volumes mainly located in the non-cartilaginous 
areas. 
3.3.4 Mechanical properties. Ball burst testing of cartilage revealed an overall reduction of stiffness in 
decellularized (9.3+/-8.4 N/mm, range 1.5-21.3) compared to native samples (18.4+/-9.3 N/mm, range 
4.4-30.2). This result demonstrates an overall reduction of the stiffness in the decellularized group, 
remaining however in the same order of magnitude as for the native. 
Tensile testing of skin showed an increase in maximum engineering stress after decellularization, along 
with an increase in dispersion of maximum stress (0.9+/-0.4 MPa for native tissues versus 1.2+/-0.6MPa 
for decellularized tissues). Strain at maximum stress was not significantly different between native (0.4+/-
0.1 MPa) and decellularized (0.4+/-0.2 MPa) tissues (See Supplementary Material 3, skin stress-strain 
curves). 
3.4 HE-ECM preservation of cytokines. The cytokine analysis revealed that essentially all 42 tested 
cytokines were measurable in skin, cartilage and fat samples. In order to quantitatively characterize 
cytokine preservation in the different tissues of the scaffold, we analyzed the degree of change of growth 
factors in each biological sample. As shown (FIG 5A), all the measured cytokines in skin samples 
collected from the decellularized scaffold decreased significantly compared to native skin samples. 
Conversely, none of the measured cytokines decreased significantly by decellularization in fat tissue, with 
the exception of IL-4 which was below detection level. Cartilage presented a middle behavior with 22/44 
cytokines significantly decreased after decellularization compared to controls. To better understand how 
the decellularization process affected cytokines in HE-ECM, we calculated the relative proportion of 
preservation for each cytokine in decellularized tissues expressed as percentage of the native mean 
abundance (FIG 5B). In order to investigate whether different cytokine subclasses were differentially 
affected by the decellularization process, the following cytokine groups were created according to 
cytokine function: 1) pro-inflammatory cytokines (IL-1β, IL-6, IFNγ, TNF-α, MIF), 2) Chemokines (IL-
16, CCL1, CCL2, CCL3, CCL7, CCL8, CCL11, CCL13, CCL15, CCL17, CCL19, CCL20, CCL21, 
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CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CXCL1, CXCL2, CXCL6, CXCL9, CXCL10, 
CXCL11) and 3) Growth factors (IL-2, IL-4, IL-8, IL-10, GM-CSF, TGF-β1, TGF-β2, TGF-β3, CXCL5, 
CXCL12). Although many cytokines exhibit pleiotropy, we classified each cytokine into one of the three 
groups. No double classifications were allowed. As shown (FIG 5C), in decellularized skin total protein 
preservation was 8.75±4.07% with similar preservation of pro-inflammatory cytokines and chemokines 
(5.88±5.0% and 7.13±7.87%, respectively). Growth factors showed a much higher percentage of 
preservation (152.68±213.84) compared to pro-inflammatory cytokines and chemokines. Similar results 
were observed in cartilage (41.99±6.73%, 19.48±11.21%, 17.30±11.53% and 78.77±80.37 of preservation 
of total protein, pro-inflammatory cytokines, chemokines and growth factor, respectively) and in fat 
(12.9±5.09%, 31.74±21.65%, 43.63±33.52%, 255.94±275.28% of preservation of total protein, pro-
inflammatory cytokines, chemokines and growth factor, respectively). Interestingly, only three of the 
forty-two cytokines (i.e., TGF-beta1, TGF-beta3 and CXCL5) showed an increase in expression levels 
when comparing decellularized and native tissues. This is likely due to more efficient protein extraction in 
the cell-empty ECMS and the increase in the ratio of pg cytokine per total ECMS weight in the 
decellularized tissues. In fat tissue, three cytokines displayed relative increase as compare to native tissue 
(i.e., IL-2, CXCL2 and CCL24), confirming the higher capacity of the adipose tissue to retain growth 
factors during the decellularization process. Apart from TGF-β1, TGF-β3 and CXCL5 the most preserved 
cytokines across tissues were IL-2, GM-CSF, CCL1, CCL24 and CXCL2 (FIG 5B).  
3.5 In vivo implantation – biocompatibility study. There was no adverse event encountered at the time 
of graft implantation. During scaffold retrieval, the surrounding abdominal wall skin appeared healthy, 
and after incision and direct implant observation, no obvious capsular formation could be identified. The 
integration with recipient tissues was satisfying in all groups with signs of macroscopic vascular 
infiltration present. At histology, the cellular infiltration was diffuse at POD15 and POD30, but less 
important at POD60, with signs of micro-vascular permeability in the deep scaffold (FIG 6A), compared 
to the native control (FIG 6A-B), even the difference was not as strong as expected, due to the 
sterilization protocol. Remodeling was globally limited. CD68+ macrophage infiltration was significant 
and located exclusively within the scaffold, being less intense and more peripheral at POD60 (FIG 6C-
F); this correlates to the CD68 staining quantification, in which the % stained area was significantly 
(p<0.0001) higher in the control native group at POD15, with reduction at POD30 so that there was now 
no difference between groups. At POD60, the native group was significantly more infiltrated than the 
decellularized group (**p<0.001). Interestingly, the decellularized group was significantly less infiltrated 
at POD60 compared to the same group at POD30 (FIG 6G). Regarding qualitative and quantitative anti-
CD3 staining, response was found very poor, in both native and decellularized samples, mainly located at 
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the surface of the scaffolds, and without great difference between groups. Flow cytometry of circulating 
rat anti-human IgG antibodies showed the following positive recipient immunization: 2/3 POD15 and 
POD30, 2/2 POD60 in control group, compared to 0/3 POD15, 1/3 POD30 and 0/2 POD60 (FIG 6H, see 
Supplementary Material 4). 
3.6 In vitro compatibility. For rASCs-seeded scaffolds, MTT staining revealed homogeneous engraftment 
of viable cells on all scaffolds. On the full-thickness scaffolds, cells were located on all tissue layers 
including the epidermal side (FIG 7A-C). Cell viability was confirmed by live/dead staining, with a few 
dead cells identified (FIG 7D-F).  
3.7 Whole-ear perfusion-bioreactor seeding. No sign of contamination was recorded during the 
experiment. At retrieval, the cultured HE-ECM appeared diffusely pink, indicating perfusion and 
impregnation of the culture medium (FIG 8A-C). CD31 staining was positive (to be compared with FIG 
2D) on the endothelial wall of vessels from various calibers, found both in superficial and deep part of the 
scaffold. Live/dead staining show intra-vascular distribution of living cells, in small and larger vessels 
(FIG 8). However, No cell nuclei could be observed with H&E staining in the large pedicles, either in the 
lumen or the vessels endothelial surface (see Supplementary Material 5) . Finally, whole-mount MTT 
vital staining allow to appreciate the seeding cover, even if segmental, of the scaffold vascular tree  (FIG 
8F).  
 
4. Discussion 
A functional, implantable and clinically applicable engineered auricle is our ultimate objective. This study 
takes important steps in achieving this goal. We were able to produce whole acellular human ears with 
route for access to the vascular tree utilizing the approach of Vascularized composite Tissue Engineering. 
We demonstrated that early findings from porcine ear engineering [18] could be applicable to a human 
auricular graft model, confirming the relevance of the pig model in a preclinical experimental approach 
for composite tissue engineering. The feasibility of using elderly postmortem human donors, even several 
days after death, was shown. This is possible because of high collagen content of composite tissue ECM 
that seems to better handle cell necrosis and proteolytic enzymes, likely due to the presence of cell 
populations with low metabolic activity and less aggressive enzymatic content, as compared to exocrine 
pancreas cells involving complex organ engineering challenges [27]. Finally, vascular tree patency was 
displayed at all levels throughout the auricular ECM scaffold. It is however important to highlight that a 
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diseased vascular tree, with extensive arteriosclerosis, can compromise perfusion and thus success in the 
decellularization. 
An important difference when comparing the present data with our porcine ear study concerned the 
adipose tissue defatting: the ability to remove nuclei was efficient with detergents, as confirmed by DAPI 
staining, but a high content of scattered oil cysts persisted, requiring an additional treatment with polar 
solvent, as recommended in non-perfused isolated human adipose tissue engineering [22]. Our polar 
solvent step resulted in successful fat removal, although DAPI staining showed nuclei removal prior to 
the step, without impairment of the vascular tree. Even if considered as a minor issue for organ 
bioengineering, the ability to completely treat the adipose tissue is critical when dealing with composite 
tissue engineering, as fat represents a major component for this type of graft, in both qualitative and 
quantitative aspects. The real question however is whether adipose tissue needs to be fully treated or not, 
as the use polar solvent is not straightforward. When considering in vivo application, persistence of lipid 
droplets can trigger a significant inflammatory reaction that may be deleterious to scaffold implantation. 
Moreover, even for in vitro application only, native adipose tissue persistence results in reduced 
engraftment of new adipocyte and thus poorer adipose tissue regeneration [23]. This illustrates the need 
for combination of decellularizing agents in VCE. Indeed, other tissues were successfully treated, with 
only some donor cells observed in the cartilage. These few remaining cells should not be an issue 
considering the significant reduction of total DNA observed in this tissue and its poor immunogenicity 
due to its avascular nature and ECM density [15]  
Following processing, the auricular ECM structural components and 3D organization were well-
preserved, which is critical for body parts in which function is directly related to the preservation of its 
form. The stiffness of the decellularized cartilage was maintained in an acceptable manner in our study, 
which applies directly to the target function of shape preservation of TE auricles, but may not be 
universally applicable to other tissue such as knee articular cartilage which experiences repetitive strain as 
its main function.  Due to the cadaveric origin and the variability of the donors in this study, such results 
provide an overall appreciation of such an assessment. In order to further determine the structural 
organization of the auricular VCE, we performed a 3D characterization. This innovative tool brings a new 
level of resolution to scaffold analysis, allowing for precise comprehension of the spatial organization of 
both native and decellularized tissue with accurate reproduction of ECM in tissue engineering. As a 
quantitative measurement, porosity was calculated based on 3D volume, which is a more accurate 
assessment than conventional 2D analysis can provide. Still, new 3D analytic tools need to be developed 
for soft tissue and organ engineering evaluation, so as to mimick the success of 3D bone tissue evaluation 
[28]. 
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Perfusion-decellularization with SDS-based protocol seems to be suitable for protection of innate 
cytokines of skin, fat and cartilage in the human ear. We showed that cytokines of different function and 
nature are preserved to a measurable extent. Overall, growth-inducing cytokines were preserved most 
frequently, followed by the cell-guiding chemokines then inflammatory cytokines. It has been previously 
demonstrated that growth factors such as TGF-β, VEGF, and bFGF are present in acellular ECM 
scaffolds, and these growth factors retain most of their biologic activity following decellularization of the 
ECM and therefore may contribute to the favorable characteristics of decellularized ECM scaffolds [29-
32]. In our study we demonstrate a better preservation of “protective” growth factors and a more 
pronounced depletion of pro-inflammatory cytokines across all analyzed tissues. In addition to the 
positive cytokine profile, we also observed distinct responses to the perfusion process of individual tissue 
ECMs in terms of protein preservation, with cartilage and fat being the most preserved tissues. Taken 
together, these findings suggest that newly colonizing cells in the ECM scaffold may benefit of the 
presence of preserved growth factors bounded to the ECM and that ECM obtained via perfusion-
decellularization are therefore very likely to increase the success rate of cell-reseeding. However, in this 
study we did not assess the biological activity of the measured cytokines. Considering the nature of the 
decellularization protocol it is possible that not all the measured cytokines will be biologically active and 
some of them would be in a denatured and inactive form. It cannot be rule out that these denatured 
cytokines may stimulate immune response against the scaffold. Future studies are warranted to assess the 
how the specific components (both structural and soluble) retained within an ECM scaffolds may activate 
the immune response and to verify whether, as recently proposed, acellular ECM scaffolds may modulate 
the host immune response towards a functional tissue replacement outcome [32]. 
We observed an overall increase of vascular resistances during scaffold production, especially during 
SDS perfusion. This phenomenon of increasing vascular pressure during perfusion-decellularization has 
been described for other organs [17,33] with a subsequent decrease in resistance after re-
endothelialization. In contrast to these findings, MAP was already back to normal values after PBS 
rinsing in our study. Considering adaptation of perfusion inflow, we question the need to adapt flow to 
follow constant ideal vascular resistance, as recommended for solid organs preservation and engineering. 
Indeed, during the initial steps, a high pressure increases the risk of damage to microcirculation and of 
edema formation. Furthermore, vascular resistances after cellular depletion likely reflect extra-vascular 
rigidity with subsequent increased pressures against flow. Thus, maintaining adequate flow, against 
increased vascular resistances, should be the goal to allow distal perfusion. 
During the in vivo part of our study, the decellularized scaffolds were well tolerated even when significant 
remodeling was observed, with an important CD68+ macrophage infiltration during the first 8 weeks 
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post-implantation. This remodeling is well-known [34,35] and part of a necessary integration period of 
the ECM by the recipient, with a related ECM mass decrease. In our study, we observed a preservation of 
the ECM structure at POD60, with less remodeling than expected for an ECM rich in collagen. The 
discrepancies observed when screening anti-donor circulating IgG may rely on the immunogenicity of the 
treated ECM itself, along with the use of cadaveric donors. For the control, the immune response was 
mild, explained by the need to use non-fresh controls from human cadavers, with reduced allogenic 
properties. This was even more obvious on the anti-CD3 qualitative and quantitative assessments, with a 
very light difference between decellularized and native groups. Moreover, the need to sterilize native 
tissues with 0.1% PCA participated in reducing allogenicity further, as PCA itself has been described as a 
decellularizing agent on its own [36]. This illustrates the need in such studies to use more sophisticated 
techniques as FACS and antibody detection, to draw conclusions about immune response. This appears to 
be the downside of using human grafts from cadaveric sources, and further studies should investigate the 
effect of procurement delay and conditions on the overall outcome and immune response in vivo. 
Nevertheless, this model is a very useful tool to study and establish VCE protocols at a direct human 
scale, with readily accessible donor supply. 
When dealing with future whole-graft scaffold recellularization strategies, it is of paramount importance 
to consider the ear as a complex 3D anatomical structure at all scales, with multilayered tissues including 
skin, cartilage, fat, nerves and blood vessels. This conceptual framework highlights the challenges of 
creating a clinically useful auricle graft based on conventional TE approaches, to provide the expected 
complexity of the living associated to a transplantable vascular tree, to allow the survival of the 
engineered ear.  Even if we had an efficient protocol readily available to adequately treat all the tissues at 
once to produce a decellularized ECM scaffold with a single vascular access, recellularization remains an 
important problem to solve. As demonstrated in this study, vascular access to facilitate seed dissemination 
and preservation of basal membranes are prerequisite factors to allow dermal perfusion of culture medium 
with subsequent cell engraftment; non-perfused TE skin construct approaches are limited in their ability 
to recellularize a scaffold [37]. Apart from skin and vessels, which can be approached in a direct manner 
for seeding, other tissue types, such as cartilage and adipose, are buried deep in the scaffold, making it 
almost impossible for any selective seeding like topical, vascular injection, or cell infusion. For these 
tissues, the ideal option relies on a single-type stem cell approach, that differentiates and replicates when 
in contact with specific ECM tissues, as demonstrated by other groups [38,39]. For the cartilage, 
combined to a whole composite scaffold, like ear or nose, the difficulty will be important, by its deep 
location it the graft and the absence of vascular access. The current strategies in cartilage engineering 
have successfully treated isolated scaffolds [7,40], but cannot be directly applied to our cadaveric 
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auricular ECM scaffold model at this time. Perichondrium and peripheral cartilage enhanced porosity 
could allow seeded cells to repopulate the decellularized cartilage adequately with further research efforts. 
The different whole-ear bioreactor seeding experiments we performed showed that the step of cadaveric 
human ear recellularization step can be reach with our current approach; we still need to improve the cell 
choices, the cells engraftment strategies, relying on perfusion-seeding methodology as well as the number 
of cells available in vitro. Regarding, this last point, we already know that, even for such a small graft, the 
number of cells needed will be prohibitive; the most pertinent strategies will be very likely to combine 
partial in vitro seeding and in vivo maturation of the scaffold.   For all these reasons, the main key to 
success is the long-term vascular reperfusion in a recipient, a shared limitation with parallel organ 
bioengineering strategies. But once a reliable vascular regeneration methodology will be available, the 
clinical applications, especially in a study already at the scale of human grafts, will be straight-forward. 
 
5. Conclusions 
Complex auricular scaffolds with preserved vasculature can be obtained from human delayed postmortem 
sources to provide a platform for further functional tissue engineered constructs. Access to an auricular 
vascular tree, for which preservation and accessibility has been obtained for the first time in this study, is 
the key step required to translate experimental science to clinical usage. Overall, perfusion-
decellularization application to body parts show great promise in generating suitable composite tissue 
scaffolds for body reconstruction. The goal of future experiments should be to improve the efficiency of 
the decellularization protocol and to improve recellularization by enhancing vascular seeded engraftment 
and density, as well as epidermal regeneration on a perfused acellular dermis. 
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Figures captions  
Figure 1:  Cadaveric ear graft perfusion-decellularization. A Native ear flap after procurement, with 
arterial (external carotid artery ECA, posterior auricular artery PAA, superficial temporal artery STA) and 
venous (external jugular vein EJV) pedicle, with anterior (left) and posterior (right) views; the arrow 
indicates the flow direction. B Perfusion-decellularization: left, after 24 hours perfusion, with evidence of 
epidermolysis and large bullae formation (arrows); right, final aspect. C Decellularized ear anterior (left) 
and posterior (right) views, with evidence of morphology preservation and oil cysts removal, after 2-
propanol solvent treatment. GAN Great Auricular Nerve. D Ear lobe section and staining with type IV 
Sudan fat staining prior (up) and after (down) polar solvent treatment. Scale bars 1 mm. E Arterial 
fluoroscopy of decellularized ear: STA and PAA are opacified. F Mean arterial pressure (MAP) evolution 
during process (n=4), at constant output. MAP expressed in mm Hg.  
 
Figure 2: Cells and antigens removal. A H&E staining comparing native (left) and decellularized (right) 
ear grafts. E epidermis, D dermis, PC perichondrium, C cartilage. Inserts show magnified details (black 
squares) of the section. B DAPI staining showing native (left) and decellularized (right) ear sections. C 
anti-type I HLA staining in native (left) versus decellularized (right) tissues. D Anti-CD31 staining in 
native (left) versus decellularized (right) tissues. E DNA content in native (N-) versus decellularized (D-) 
tissues, expressed in ng/mg wet weight. Analysis performed on skin (n=6), fat (n=4) and cartilage (n=3) 
samples from native ear (n=3) and HE-ECM (n=3). Statistics were performed using unpaired student t-
test, mean ± SEM, ***p<0.001, ** p<0.01, * p<0.05. Scale bars: upper raw, 1 mm for the section 
overview, 200 µm for the inserts ; lower raw 100 µm. 
 
Figure 3: ECM major proteins and 2D structure preservation.  A-F Histology stainings by A 
Masson’s trichrome of skin, B Type I collagen of skin, C type II collagen of cartilage, D type IV collagen 
in dermis, E Alcian blue and F Safranin O in cartilage, of native (upper raw) and decellularized (lower 
raw) tissues; DEJ, dermo-epidermal junction. G-J SEM evaluation of G dermal surface with preserved 
dermal papillae (DP), H dermal section with appreciation of DEJ, I cartilage section and J adipose tissue, 
from acellular scaffolds; insert represent native samples. K-M Major ECM content quantification: K 
Collagen, L Elastin and M GAGs; expressed in µg/mg wet weight of tissue. Analysis performed on skin 
(n=6), fat (n=4) and cartilage (n=3) samples from native ear (n=3) and HE-ECM (n=3) Statistics were 
performed using unpaired student t-test, mean ± SEM, ** p<0.01, * p<0.05. Scale bars: 100 µm. 
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Figure 4: ECM 3D-histology reconstruction. A Methodology: native and decellularized ear samples are 
serial sectioned, then digitalized and treated for 3D alignment and reconstruction with a specific software. 
2D/3D scale bars: 1 mm. B Biopsy location (left), 3D-histology volume reconstruction and virtual 
sampling locations (middle) for 3D subunit elementary tissue reconstruction: connective tissue, cartilage 
and skin, from native and decellularized samples (right). 3D Scale bars: 75m. C Porosity value 
calculated from the ratio between non-stained and stained area in the whole 3D biopsy volume from 
native and decellularized samples, with inclusion of cartilage layer. 
Figure 5: Cytokines quantification. A Heatmap showing changes in abundances of 42 absolutely 
quantified cytokines in skin, fat and cartilage biopsies from four native (N-) and three decellularized (D-) 
scaffolds. Individual protein pictogram abundance per milligram of tissue was log2 transformed. Yellow 
boxes correlate with lower protein concentration and red boxes with higher protein concentration (see 
scale). Crossed boxes indicate samples under the detection limit. *p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001 by two-sample t-tests with Benjamini, Krieger and Yekutieli correction to compare native 
and decellularized values. B Heatmap showing cytokine preservation after decellularization in skin, fat 
and cartilage as percentage of native tissues abundance. White boxes correlate with lower preservation 
and blue boxes with higher cytokine preservation. Purple boxes indicate increased cytokine levels as 
compared to native tissues (≥ 100 %). C Relative preservation of total protein extract (grey), pro-
inflammatory cytokines (yellow), chemokines (green) and growth factors (blue) in decellularized skin, fat 
and cartilage. Highly preserved cytokines (>100%) are indicated. Data presented as mean±SD. *p<0.05; 
*** p<0.001 by one-way ANOVA with Tukey’s correction. 
Figure 6: In vivo study, subcutaneous implantation in rat. A-B Macroscopic assessment: A HE-ECM 
implant at time of explantation, external aspect (left) and section aspect (right) integration between layers 
of skin (S) and muscle (M) of the recipient’s abdominal wall, with no signs of capsular formation and 
evidence of growing vessels (arrows); B Comparison with native control with more although limited 
peripheral reaction(left) and absence of neo-vessels at section inspection (right); C-D HE-ECM Masson’s 
trichrome assessment at C postoperative day POD15 and D POD60, with diminution of cellular 
infiltration, limited remodeling and patent blood vessels (arrows in D insert). M Muscle. E-F Macrophage 
infiltration CD68 IHC staining at E POD15, F POD60; windows enlarged views in the inserts. G CD68 
quantification at POD15, POD30 and POD60 in native (black) and decellularized (grey) implants;  H-I 
Lymphocyte infiltration CD3 IHC staining at H POD15, I POD60; windows enlarged views in the inserts. 
J CD3 quantification at POD15, POD30 and POD60 in native (black) and decellularized (grey) implants; 
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K Flow cytometry of anti-human circulating IgG antibodies in the rat recipient at D0 (green curve) and 
POD60 (purple curve), in native (above) and decellularized (below) recipients. Selected curves originate 
from the most representative positive (control) and negative (decellularized) flow cytometries (for 
complete data set, see supplementary material 3). *p<0.05;  **p<0.001;  **** p<0.0001. Scale bars: 1mm 
in overview section, 200m in inserts. 
Figure 7: In vitro compatibility. Static seeding with rat adipose-derived Stem Cells (ASC) 3.6x10
4
 cells/ 
cm
2 
for 14 days: A-C Seeded scaffold and enlarged view, and observation of MTT staining, D-F 
Live/dead vital staining examination on whole-mount, of arterial pedicle (upper raw), dermis (middle 
raw) and full-thickness (lower raw) samples from HE-ECM; D dermis, C cartilage.  Scale bars: 1 mm. 
Figure 8: Whole-ear scaffold perfusion-bioreactor seeding. A Perfusion-sterilization with 0.1% 
peracetic acid and PBS rinsing. B Sterile mounting in perfusion-bioreactor, and immersion with culture 
medium, prior to cell seeding C Ear graft scaffold at time of retrieval, with pinky aspect as sign of proper 
culture medium perfusion and ECM impregnation. D CD31 staining positivity (arrows), in deep (left) and 
superficial (right) scaffold structure. E-F Whole-mount staining and direct microscope observation after 
E Live/dead and F MTT vital stainings. Scale bars: 200 µm, with exception of  MTT observation with 
microscope 10x magnification: 1 mm. 
Supplementary material 1:  HE-ECMs fluoroscopy video. Video shows the dynamic perfusion of a HE-
ECM compared to a native ear graft during contrast agent arterial injection. 
Supplementary material 2:  DNAse effect on nucle removal. H&E sections of native (above), before 
(middle) and after below) the DNAse perfusion step, without notable differences in terms of nuclei 
staining. Scale bar: section overview 1mm; inserts 200m. 
Supplementary material 3:  Skin tensile strength test. Uniaxial tension stress-strain curves of native and 
decellularized skin tissues. After decellularization, the maximum stress increases (along with its 
dispersion) but the strain at maximum stress is not significantly different. 
Supplementary material 4:  Rat anti-human IgG flow cytometry complete data. Flow cytometry of 
anti-human circulating IgG antibodies in the rat recipient at D0 (green curve) and POD60 (purple curve), 
in native (above) and decellularized (below) recipients. 
Supplementary material 5:  Arterial carotid artery microscopic assessment after endothelial cell 
seeding. H&E sections staining of the external carotid artery scaffold after re-endothelialization (global 
view, up; higher magnification, below). Scale bar: 200 µm. 
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Statement of significance  
 
The ear is emblematic in the biofabrication of tissues and organs. Current regenerative medicine 
strategies, with matrix from donor tissues or 3D-printed didn’t reach any application for reconstruction, 
because critically missing a vascular tree to perfuse and to transplant it. We previously described the 
production of vascularized and cell-compatible scaffolds, from porcine ear grafts; in this study, we then 
applied findings directly to human auricles harvested from postmortem donors, providing a perfusable 
matrix, retaining the ear’s original complexity, that even hosts new viable cells after seeding. This 
approach unlocks the ability to achieve an auricular tissue engineering approach, associated with 
possible clinical translation. 
 
 
 
